Published source snapshot
EPO Evening Primrose Oil 500
LifeLink · US label facts
Label IDlbl_dsld_11879_10b6bb5c49b63239
Serving size2 Softgel(s)
Serving formSoftgel(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Blend (Fatty Acid or Fat/Oil Supplement) DSLD row path: root.0; DSLD ingredientId: 47337 | 1000 mg | 1000 mg / as_labeled | Total Omega Fatty Acids |
| Linoleic Acid cis-Linoleic acid (Alt. Name: LA); DSLD row path: root.1; DSLD ingredientId: 285242 | 730 mg | 730 mg / as_labeled | Linoleic Acid |
| Gamma Linolenic Acid DSLD row path: root.2; DSLD ingredientId: 285164 | 90 mg | 90 mg / as_labeled | Gamma-Linolenic Acid |
| Vitamin E Natural Vitamin E (Form: D-alpha-tocopheryl acetate); DSLD row path: root.3; DSLD ingredientId: 280738 | 26 IU | 26 IU / as_labeled | Vitamin E |
| Gelatin Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 3715. | Not stated | missing_quantity | Gelatin |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim Suggested/Recommended/Usage/Directions: Suggested Use: 2 to 5 softgels daily as a dietary supplement.
- label_claim General Statements: All Other Content: Evening Primrose Oil is a rich source of gamma-linoleic acid and linoleic acid - two omega-6 fatty acids from which the body makes prostaglandins, which regulate such processes as bronchial constriction, male sexual function, nerve and kidney function, blood pressure, immunity, blood sugar levels, stomach acid, mucus production in the stomach lining, and uterine stimulation. Epo is typically used to reduce cyclic breast pain and rheumatoid arthritis inflammations, to normalize cholesterol levels, and to decrease atherosclerotic plaques.
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 11879
- Local snapshot
- snap_dsld_11879_10b6bb5c49b63239d0929db2
- Content hash
10b6bb5c49b63239d0929db2b0ac02e139939179bfbad177456ec6178f49a690- Source version
- Not stated
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.